11 Nov 2022 , 08:41 AM
Net profit of Fredun Pharmaceuticals rose 71.20% to Rs 3.15 crore in the quarter ended September 2022 as against Rs 1.84 crore during the previous quarter ended September 2021. Sales rose 26.66% to Rs 68.84 crore in the quarter ended September 2022 as against Rs 54.35 crore during the previous quarter ended September 2021.
| Particulars | Quarter Ended | ||
| ? | Sep. 2022 | Sep. 2021 | % Var. |
| Sales | 68.84 | 54.35 | 27 |
| OPM % | 9.86 | 7.51 | – |
| PBDT | 4.93 | 3.03 | 63 |
| PBT | 4.21 | 2.51 | 68 |
| NP | 3.15 | 1.84 | 71 |
Powered by Capital Market – Live News
Related Tags
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2025, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
